Defining Trajectories of Response in Psoriasis Patients Treated with Biologic Therapies
Br J Dermatol, 2021.
Geifman N, Azadbakht N, Zeng J, Wilkinson T, Dand N, Buchan I, Stocken D, Di Meglio P, Warren RB, Barker JN; Reynolds NJ, Barnes MR, Smith CH, Griffiths CEM, Peek N; BADBIR Study Group, on behalf of the PSORT Consortium.
Read publication: Br J Dermatol 2021
Related
The British Association of Dermatologists Biologics and Immunomodulators Register: a centenary celeb...
Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective c...
Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab a...
0 Comments